loadpatents
Patent applications and USPTO patent grants for Jones; Paul Alexander.The latest application filed is for "differential diagnosis".
Patent | Date |
---|---|
Combination formulation Grant 11,110,185 - Meijer , et al. September 7, 2 | 2021-09-07 |
Differential diagnosis Grant 10,980,899 - Jones , et al. April 20, 2 | 2021-04-20 |
Differential Diagnosis App 20190328909 - JONES; Paul Alexander ;   et al. | 2019-10-31 |
Combination Formulation App 20180303960 - Meijer; Andreas Richard ;   et al. | 2018-10-25 |
Risk Stratification App 20180147305 - Provost; Jean-Claude ;   et al. | 2018-05-31 |
Risk Stratification App 20180147304 - Provost; Jean-Claude ;   et al. | 2018-05-31 |
Carbazole compounds for in vivo imaging Grant 9,951,011 - Trigg , et al. April 24, 2 | 2018-04-24 |
S-enantiomer Of Tetracyclic Indole Derivative As Pbr Ligands App 20160222024 - Trigg; William John ;   et al. | 2016-08-04 |
Carbazole Compounds For In Vivo Imaging App 20160214936 - TRIGG; William John ;   et al. | 2016-07-28 |
In vivo imaging method for cancer Grant 9,314,541 - Jones April 19, 2 | 2016-04-19 |
In vivo imaging method of mood disorders Grant 9,168,317 - Jones October 27, 2 | 2015-10-27 |
In Vivo Imaging Method For Cancer App 20130183240 - Jones; Paul Alexander | 2013-07-18 |
In Vivo Imaging Method Of Mood Disorders App 20130177501 - Jones; Paul Alexander | 2013-07-11 |
[18f] Labelled Analogues Of Flumazenil As In Vivo Imaging Agents App 20120189547 - Woodcraft; John ;   et al. | 2012-07-26 |
In Vivo Imaging Method App 20110236307 - Jones; Paul Alexander | 2011-09-29 |
Imaging The Central Nervous System App 20110027178 - Jones; Paul Alexander ;   et al. | 2011-02-03 |
Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound App 20060287353 - Jones; Paul Alexander ;   et al. | 2006-12-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.